Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
Shelly Kalaora(Harvard University), Yardena Samuels(Weizmann Institute of Science), Erez Greenstein(Weizmann Institute of Science), Polina Greenberg(Weizmann Institute of Science), Brett W. Carter(The University of Texas MD Anderson Cancer Center), Dan Reshef(Weizmann Institute of Science), Xingzhi Song(The University of Texas MD Anderson Cancer Center), Eilon Barnea(Technion – Israel Institute of Technology), Tana Omokoko(Institute of Pathology Celle), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Cara Haymaker(The University of Texas MD Anderson Cancer Center), Chantale Bernatchez(BMC Software (United States)), Ronen Levy(Weizmann Institute of Science), Eytan Ruppin(Cedars-Sinai Medical Center), Tali Feferman(Weizmann Institute of Science), Sushant Patkar(National Institutes of Health), Zachary A. Cooper(AstraZeneca (Singapore)), Steven A. Rosenberg(National Cancer Institute), Yochai Wolf(Sheba Medical Center), Michal Lotem(Hadassah Medical Center), Guy Shakhar(Weizmann Institute of Science), Uğur Şahin(Johannes Gutenberg University Mainz), Juliane Quinkhardt(Institute of Pathology Celle), Nouar Qutob(Weizmann Institute of Science), Caitlin Creasy(The University of Texas MD Anderson Cancer Center), Alexandre Reuben(The University of Texas MD Anderson Cancer Center), Arie Admon(Technion – Israel Institute of Technology), Jianhua Zhang(XinHua Hospital), Nir Friedman(Weizmann Institute of Science), Marie-Andrée Forget(The University of Texas MD Anderson Cancer Center), Ofra Golani(Weizmann Institute of Science), Xizeng Mao(The University of Texas MD Anderson Cancer Center), Itay Tirosh(Weizmann Institute of Science)
Cited by 100
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
|Cell|2017|2.6k
mRNA-based therapeutics — developing a new class of drugs
|Nature Reviews Drug Discovery|2014|2.4k